إعلان
إعلان
CYTK
Cytokinetics Inc.
61.71
USDبرعاية
-1.83
-2.88%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
61.81
+0.10
+0.16%
تقارير أرباح CYTK
النسبة الإيجابية المفاجئة
CYTK تفوق 14 من 39 آخر التقديرات.
36%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$7.79M
/-$1.44
التغير الضمني من Q3 25 (Revenue/ EPS)
+302.45%
/-43.31%
التغير الضمني من Q4 24 (Revenue/ EPS)
-53.97%
/+14.29%
Cytokinetics Inc. earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, CYTK reported earnings of -2.54 USD per share (EPS) for Q3 25, missing the estimate of -1.61 USD, resulting in a -58.24% surprise. Revenue reached 1.94 مليون, compared to an expected 3.63 مليون, with a -46.62% difference. The market reacted with a +1.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of -1.44 USD, with revenue projected to reach 7.79 مليون USD, implying an decrease of -43.31% EPS, and increase of 302.45% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Cytokinetics Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cytokinetics Inc. reported EPS of -$2.54, missing estimates by -58.24%, and revenue of $1.94M, -46.62% below expectations.
How did the market react to Cytokinetics Inc.'s Q3 2025 earnings?
The stock price moved up 1.88%, changed from $59.19 before the earnings release to $60.30 the day after.
When is Cytokinetics Inc. expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Cytokinetics Inc.'s next earnings report?
Based on 22
analysts, Cytokinetics Inc. is expected to report EPS of -$1.44 and revenue of $7.79M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان